Tranexamic acid is administered to patients with documented disease and increased fibrinolytic activity in the plasma that does not respond to diet. This was not the case in our patient 15.
Este último "aplica" para pacientes con enfermedad documentada y aumento en la actividad fibrinolítica plasmática que no responde a dieta, aspecto que no concierne al paciente en estudio 15.